Jennifer English

Head of Pricing Contracting at Ipsen

Speaker

Jen English is the Head - Pricing, Contracting, New Products, Licensing & Acquisitions on Ipsen Biopharmaceuticals US Value & Access team. She is responsible for leading the overall pricing and contracting strategy and execution of current and future portfolio products. She also serves as the US V&A lead working with her team on the licensing & acquisition activities.

Jen has been in the pharmaceutical industry since 1996 and entered the world of Managed Markets in 2000. She has established herself as a subject matter expert in market access strategy, contract operations, gross-to-net forecasting, government program price reporting and compliance. During her prior role at Eisai, she led the order to cash process, which includes: Customer Service, Chargebacks, Rebates, Government Price Reporting and Accounts Receivable. Prior to Eisai, Jen worked at Insmed Incorporated, where she was hired in preparation for the first commercial product launch. She established the company’s pricing and contract strategy, Pricing Committee structure, commercial and government contract operations and the government price reporting program. Her uniquely situated role enabled her to oversee gross-to-net forecasting and provide analytical contributions to the Board, Global Product Teams, Finance, Sales, Marketing and Market Access departments. Additionally, Jen has held positions of increasing responsibility at: Acorda Therapeutics, Aptalis Pharma, Optimer Inc. and Nycomed US Inc. She began her biopharma career at Bristol-Myers Squibb Company.

Jen has a BA in History/Political Science from Rutgers University, a Post-BA Paralegal Certificate from Montclair State University, and an MBA from Rutgers Graduate School of Management. She is a frequent speaker at Government Pricing, Contracting and Gross-to-Net conferences. Additionally, she is a guest lecturer for the Rutgers MBA Pharmaceutical Program, sharing her subject matter knowledge on the US pharmaceutical pricing, payer and gross-to-net landscape each semester.